The Industry Doesn't Wait.
Neither Should You

Early bird pricing is in effect. Secure your spot now.

Explore Hot Topics

FDA Tightens Expectations for Biosimilar Promotion

Explore 2025 US FDA Q&A Guidance on rendering information about reference and biosimilar products in promotional labeling and advertisements.

Read Global Forum

Regulatory Affairs Training Course

Virtual training course explains FDA regulations and expectations for content, submission, and review of INDs and NDAs.

Learn More

DIA-MHRA Global Summit

Developed in partnership with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), this inaugural gathering will showcase how the UK enables innovation across the full pathway—from early development and clinical investigation to regulation, evidence generation, and real-world adoption.

Global Forum, DIA's Digital Magazine

Uncover expert insights through global and regional coverage of the discovery, development, regulation, surveillance, and marketing of healthcare products, including interviews with thought leaders and topical summaries from educational events.

READ LATEST ISSUE